Skip to content

Clinical trials

Observational Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Clear all

480 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20032
20045
20055
200613
20077
200817
200914
201018
201115
201213
201315
201414
201518
201620
201725
201820
201923
202030
202130
202239
202338
202431
202527
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed209
Recruiting103
Unknown status61
Terminated37
Not yet recruiting29
Active, not recruiting27
Withdrawn8
Enrolling by invitation5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene24
Takeda12
Bristol-Myers Squibb10
National Cancer Institute (NCI)10
Assistance Publique - Hôpitaux de Paris8
Memorial Sloan Kettering Cancer Center8
Pfizer8
iOMEDICO AG8
Assiut University7
Wake Forest University Health Sciences7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma480
Lymphoma64
Lymphoma, Non-Hodgkin47
Neoplasms, Plasma Cell46
Leukemia, Lymphocytic, Chronic, B-Cell44
Leukemia41
Myelodysplastic Syndromes40
Leukemia, Myeloid, Acute36
Hodgkin Disease35
Precursor Cell Lymphoblastic Leukemia-Lymphoma33

Trials

Showing 1 to 25 of 480. Each trial links to its page on Pharma Observatory.

380 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.